Efficacy and Side Effects of Q-Switched Ruby Laser Treatment of Solar Lentigines in Two Different Fitzpatrick Skin Types II and IV
Sponsor study identifier
interventional
90
1 country
1
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
The purpose of this study is a comparison of efficacy and side effects of Q-switched Ruby laser treatment for solar lentigines in two different skin types II and IV.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 2006
Date type not reportedThis date has not been verified as actual or estimated.
October 10, 2006
Actual (reported)October 11, 2006
Actual (reported)Clinical Clearance
Side Effects
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Skin Research Center, Shohada-e Tajrish Hospital, Shaheed Beheshti Medical University
Tehran, Tehran Province, 19899, Iran
Parviz Toossi, M.D.
Shahid Beheshti University of Medical Sciences
First Submitted
October 10, 2006
First Posted
October 11, 2006
Study Start
November 2005
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
September 2006
Date type not reportedContact the study team to confirm eligibility.
This date has not been verified as actual or estimated.
Last Updated
June 4, 2008
Record last verified: 2008-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: